These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32883555)

  • 21. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.
    Madhi SA; Dangor Z; Heath PT; Schrag S; Izu A; Sobanjo-Ter Meulen A; Dull PM
    Vaccine; 2013 Aug; 31 Suppl 4():D52-7. PubMed ID: 23973347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines.
    Paoletti LC; Rench MA; Kasper DL; Molrine D; Ambrosino D; Baker CJ
    Infect Immun; 2001 Nov; 69(11):6696-701. PubMed ID: 11598040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.
    Tapia MD; Sow SO; Tamboura B; Tégueté I; Pasetti MF; Kodio M; Onwuchekwa U; Tennant SM; Blackwelder WC; Coulibaly F; Traoré A; Keita AM; Haidara FC; Diallo F; Doumbia M; Sanogo D; DeMatt E; Schluterman NH; Buchwald A; Kotloff KL; Chen WH; Orenstein EW; Orenstein LAV; Villanueva J; Bresee J; Treanor J; Levine MM
    Lancet Infect Dis; 2016 Sep; 16(9):1026-1035. PubMed ID: 27261067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.
    Steinhoff MC; Katz J; Englund JA; Khatry SK; Shrestha L; Kuypers J; Stewart L; Mullany LC; Chu HY; LeClerq SC; Kozuki N; McNeal M; Reedy AM; Tielsch JM
    Lancet Infect Dis; 2017 Sep; 17(9):981-989. PubMed ID: 28522338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.
    Munoz FM; Patel SM; Jackson LA; Swamy GK; Edwards KM; Frey SE; Petrie CR; Sendra EA; Keitel WA
    Vaccine; 2020 Jul; 38(33):5355-5363. PubMed ID: 32571718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine.
    Shahid NS; Steinhoff MC; Hoque SS; Begum T; Thompson C; Siber GR
    Lancet; 1995 Nov; 346(8985):1252-7. PubMed ID: 7475716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.
    Pollard AJ; Launay O; Lelievre JD; Lacabaratz C; Grande S; Goldstein N; Robinson C; Gaddah A; Bockstal V; Wiedemann A; Leyssen M; Luhn K; Richert L; Bétard C; Gibani MM; Clutterbuck EA; Snape MD; Levy Y; Douoguih M; Thiebaut R;
    Lancet Infect Dis; 2021 Apr; 21(4):493-506. PubMed ID: 33217361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunogenicity and safety of Group B Streptococcal maternal vaccines: A systematic review.
    Bjerkhaug AU; Ramalingham S; Mboizi R; Le Doare K; Klingenberg C
    Vaccine; 2024 Jan; 42(2):84-98. PubMed ID: 38072754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial.
    Perrett KP; Halperin SA; Nolan T; Martínez Pancorbo C; Tapiero B; Martinón-Torres F; Stranak Z; Virta M; Vanderkooi OG; Kosina P; Encinas Pardilla MB; Cristobal García I; Zuccotti GV; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Marcos Fernández M; Rodríguez Zambrano MÁ; Martín García A; Asenjo de la Fuente JE; Camacho Marín MD; de la Calle Fernández-Miranda M; Romero Espinar Y; Marchisio PG; Manzoni P; Mesaros N
    Vaccine; 2020 Feb; 38(8):2095-2104. PubMed ID: 31776029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?
    Oster G; Edelsberg J; Hennegan K; Lewin C; Narasimhan V; Slobod K; Edwards MS; Baker CJ
    Vaccine; 2014 Aug; 32(37):4778-85. PubMed ID: 24992717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.
    Odutola A; Ota MOC; Antonio M; Ogundare EO; Saidu Y; Owiafe PK; Worwui A; Idoko OT; Owolabi O; Kampmann B; Greenwood BM; Alderson M; Traskine M; Swinnen K; Verlant V; Dobbelaere K; Borys D
    Vaccine; 2019 May; 37(19):2586-2599. PubMed ID: 30975570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
    August A; Glenn GM; Kpamegan E; Hickman SP; Jani D; Lu H; Thomas DN; Wen J; Piedra PA; Fries LF
    Vaccine; 2017 Jun; 35(30):3749-3759. PubMed ID: 28579233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial.
    Perrett KP; Halperin SA; Nolan T; Carmona Martínez A; Martinón-Torres F; García-Sicilia J; Virta M; Vanderkooi OG; Zuccotti GV; Manzoni P; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Stranak Z; Merino Arribas JM; Cilleruelo Ortega MJ; Miranda-Valdivieso M; Arias Novas B; Ramos Amador JT; Omeñaca F; Baca M; Marchisio PG; Mesaros N
    Vaccine; 2020 Feb; 38(8):2105-2114. PubMed ID: 31776027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case-control study.
    Saukkoriipi A; Silmon de Monerri NC; Toropainen M; Lindholm L; Veijola R; Toppari J; Knip M; Radley D; Gomme E; Jongihlati B; Anderson AS; Palmu AA; Simon R
    Lancet Microbe; 2024 Jul; 5(7):689-696. PubMed ID: 38679040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial.
    Karita E; Nyombayire J; Ingabire R; Mazzei A; Sharkey T; Mukamuyango J; Allen S; Tichacek A; Parker R; Priddy F; Sayinzoga F; Nsanzimana S; Robinson C; Katwere M; Anumendem D; Leyssen M; Schaefer M; Wall KM
    Trials; 2022 Jun; 23(1):513. PubMed ID: 35725488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Association Between Breast Milk Group B Streptococcal Capsular Antibody Levels and Late-onset Disease in Young Infants.
    Dangor Z; Khan M; Kwatra G; Izu A; Nakwa F; Ramdin T; Fredericks J; Lala SG; Madhi SA
    Clin Infect Dis; 2020 Mar; 70(6):1110-1114. PubMed ID: 31056692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants.
    Dangor Z; Kwatra G; Izu A; Adrian P; Cutland CL; Velaphi S; Ballot D; Reubenson G; Zell ER; Lala SG; Madhi SA
    Vaccine; 2015 Nov; 33(48):6793-9. PubMed ID: 26478200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults.
    Kotloff KL; Fattom A; Basham L; Hawwari A; Harkonen S; Edelman R
    Vaccine; 1996 Apr; 14(5):446-50. PubMed ID: 8735558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
    Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
    Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.